-+ 0.00%
-+ 0.00%
-+ 0.00%

NextCure, Simcere to present Phase 1 SIM0505 solid tumor data at ASCO 2026

PUBT·04/21/2026 14:15:38
Listen to the news
NextCure, Simcere to present Phase 1 SIM0505 solid tumor data at ASCO 2026
  • NextCure disclosed Phase 1 findings from SIM0505, an investigational CDH6-targeting antibody-drug conjugate for advanced solid tumors, will be presented at ASCO 2026.
  • Poster presentation is scheduled for June 1, 2026, in Gynecologic Cancer session in Chicago.
  • Update signals continued clinical progress in NextCure collaboration with Simcere to advance SIM0505 development in solid tumors.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextCure Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604211015PRIMZONEFULLFEED9693745) on April 21, 2026, and is solely responsible for the information contained therein.